SEARCH
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

More premies driving neonatal market in Europe: report Despite being "saturated" the European infant care solutions market is growing due to a rise in preterm births

MR-guided focused ultrasound is a possible “cost-effective strategy” for uterine fibroid treatment OHTAC recommends the procedure based on economic analysis

Rayence gets FDA nod for RU-3000 Digital Universal Radiography System First U-arm marketed by Rayence in U.S.

Imaging informatics accelerates change-agent role in ACA transition How imaging informatics quickly transformed the change-agent role in ACA translation

Study finds correlation between gun wound patients and stock market performance Hospitals may now have a new incentive for monitoring national economics

Siemens' tomosynthesis add-on for mammography platform scores FDA approval Provides a wide angle 50 degree angulation arc

Los Alamos National Laboratory creates ultra-low-field MRI for developing countries and battlefields Radio signals 50 miles away can interfere with these detectors

IBA's ProteusPLUS will be first proton therapy system in the Netherlands The two-gantry configuration will be installed in partnership with University Medical Center Groningen

Health IT Viewpoints Industry experts share advice and discuss the challenges

RFID – a passive solution How RFID is a low cost alternative to most RTLS infrastructures

A human embryo that
was fertilized by IVF
(Courtesy of Dr. B. Behr and the
Clinical Embryology Laboratory
at the Stanford IVF Clinic)

A new method predicts the success of in vitro fertilization

by Olga Deshchenko , DOTmed News Reporter
A novel method can help predict with 70 percent accuracy whether a woman undergoing in vitro fertilization (IVF) treatment for the second time will become pregnant, a new study found.

Researchers at the Stanford University School of Medicine identified four factors that determine a woman's chances of getting pregnant from an IVF cycle. Dr. Mylene Yao, an assistant professor of obstetrics and gynecology at the university, led the research.

Story Continues Below Advertisement

Fully integrated PACS, RIS and Voice Recognition at an affordable price

We fit our RIS/PACS to match your workflow, rather than the other way around! Call us at 866-949-7227 or click here to visit our website & see our Advanced Mammography Workstations & Mammography Tracking System built into RIS



"We developed this prediction tool to provide high quality, personalized information that women and their physicians could use to support their decision-making in IVF," Yao wrote in an e-mail to DOTmed News. "This prediction tool also paves the way towards research that will help us better understand mechanisms of infertility."

During an IVF treatment, a woman is given drugs to stimulate ovulation. Her eggs are then removed from the ovaries and combined with sperm in a culture dish. Doctors then use a variety of criteria to determine which embryos produced in the IVF cycle are most likely to result in a live birth. However, the factors doctors take into consideration are not personalized.

According to the Society for Assisted Reproductive Technology, IVF cycles result in pregnancy for women using their own eggs about 18 to 45 percent of the time, depending on age and other variables.

Yao and her team of researchers analyzed clinical data from 665 IVF cycles performed at Stanford in 2005. They examined 30 different variables and looked at the connection of each variable with the IVF outcome. The researchers found that four factors were most important in determining a woman's chance of becoming pregnant through an IVF cycle: total number of embryos, number of eight-cell embryos, percentage of embryos that stopped dividing and would die, and the woman's follicle-stimulating hormone level (a measurement that estimates ovarian function).

Yao said the new method has a lot of implications for women trying to decide to go through a second IVF treatment.

"First, the ability to use information from the first IVF treatment to predict outcomes in subsequent cycles may cause the first IVF treatment to be viewed as a prediction test, in addition to being a treatment," Yao said. "The availability of personalized information may encourage more women to take at least one IVF treatment."

Yao also said patients who may decide to drop out after the first failed treatment can make a more informed decision about continuing with further IVF treatments.

"Results pertaining to the relative influence of each factor with respect to outcome prediction will also form new paradigms for thinking about the causes for IVF, and how to develop treatments that will target specific mechanisms," said Yao.

Yao and her collaborator, Wing Wong, have founded a company together called Univfy Inc. to develop and market the new method, she said.

"We hope to make this technology accessible to patients and physicians nationwide, subject to FDA clearance," Yao said.





Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED